1/15
07:02 pm
govx
Portal Atlanta at Science Square Grows to Over 30 Member Companies, Marking Major Milestone 15 Months After Launch [Yahoo! Finance]
Medium
Report
Portal Atlanta at Science Square Grows to Over 30 Member Companies, Marking Major Milestone 15 Months After Launch [Yahoo! Finance]
1/6
09:12 am
govx
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week [Yahoo! Finance]
High
Report
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week [Yahoo! Finance]
12/19
06:32 am
govx
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine [Yahoo! Finance]
High
Report
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine [Yahoo! Finance]
12/17
09:22 am
govx
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026 [Yahoo! Finance]
High
Report
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026 [Yahoo! Finance]
12/16
07:06 pm
govx
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design [Yahoo! Finance]
High
Report
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design [Yahoo! Finance]
12/15
10:01 am
govx
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients [Yahoo! Finance]
Low
Report
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients [Yahoo! Finance]
12/11
09:14 am
govx
GeoVax Addresses Identification of New Mpox Variant [Yahoo! Finance]
Medium
Report
GeoVax Addresses Identification of New Mpox Variant [Yahoo! Finance]
11/19
08:20 am
govx
GeoVax Labs (NASDAQ:GOVX) had its price target lowered by analysts at D. Boral Capital from $9.00 to $6.00. They now have a "buy" rating on the stock.
Low
Report
GeoVax Labs (NASDAQ:GOVX) had its price target lowered by analysts at D. Boral Capital from $9.00 to $6.00. They now have a "buy" rating on the stock.
11/14
06:06 pm
govx
Geovax Labs Inc (GOVX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... [Yahoo! Finance]
High
Report
Geovax Labs Inc (GOVX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... [Yahoo! Finance]
11/13
10:47 pm
govx
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript [Seeking Alpha]